Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S5 from Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control
  1. Home
  2. Publications
  3. Figure S5 from Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control

Figure S5 from Tumor Integrin-Targeted Glucose Oxidase Enzyme Promotes ROS-Mediated Cell Death that Combines with Interferon Alpha Therapy for Tumor Control

Authors:
  • JSJordan A. Stinson
    Jordan A. Stinson
  • ASAllison Sheen
    Allison Sheen
  • BLBrianna M. Lax
    Brianna M. Lax
  • GYGrace N. Yang
    Grace N. Yang
  • LDLauren Duhamel
    Lauren Duhamel
  • LSLuciano Santollani
    Luciano Santollani
  • EFElizabeth Fink
    Elizabeth Fink
  • JPJoseph R. Palmeri
    Joseph R. Palmeri
  • KWKarl Dane Wittrup
    Karl Dane Wittrup

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.32711219
Abstract
Cross-presentation assay myeloid cell gating strategy
Keywords
  • BIOLOGICAL AGENTS & THERAPIES
  • CELL DEATH AND SENESCENCE
  • FERROPTOSIS
  • IMMUNOTHERAPY
  • COMBINATION IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.